Key result
This review proposes a cardiac impairment classification and discusses therapeutic management options for cardiomyopathy in patients with Duchenne muscular dystrophy.
This review proposes a cardiac impairment classification and discusses therapeutic management options for cardiomyopathy in patients with Duchenne muscular dystrophy.
Duchenne muscular dystrophy (DMD) is an inherited myogenic disorder due to mutations in the dystrophin gene on chromosome Xp21.1. The clinical picture included peripheral muscle weakness, cardiomyopathy and chronic respiratory insufficiency. In this paper, the authors review cardiac involvement in patients with DMD, propose a cardiac impairment classification and discuss therapeutic management options.
No takes yet. Share an insight, caveat, or question.
Fayssoil et al. (2017) conducted a review in Duchenne muscular dystrophy (DMD). This review proposes a cardiac impairment classification and discusses therapeutic management options for cardiomyopathy in patients with Duchenne muscular dystrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: